vs
因塞特(INCY)与Rollins, Inc.(ROL)财务数据对比。点击上方公司名可切换其他公司
因塞特的季度营收约是Rollins, Inc.的1.4倍($1.3B vs $906.4M),因塞特净利率更高(23.8% vs 11.9%,领先11.9%),因塞特同比增速更快(20.9% vs 10.2%),过去两年因塞特的营收复合增速更高(10.4% vs 0.8%)
因塞特是总部位于美国特拉华州威尔明顿的跨国制药企业,目前在北美、欧洲及亚洲多地设有生产基地与研发中心,专注于创新药物的研发、生产及商业化,为全球患者提供优质的治疗选择。
Rollins, Inc.是北美知名虫害防治服务商,面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务,覆盖北美、英国等市场,在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
INCY vs ROL — 直观对比
营收规模更大
INCY
是对方的1.4倍
$906.4M
营收增速更快
INCY
高出10.7%
10.2%
净利率更高
INCY
高出11.9%
11.9%
两年增速更快
INCY
近两年复合增速
0.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $1.3B | $906.4M |
| 净利润 | $303.3M | $107.8M |
| 毛利率 | — | — |
| 营业利润率 | 23.7% | 16.1% |
| 净利率 | 23.8% | 11.9% |
| 营收同比 | 20.9% | 10.2% |
| 净利润同比 | 91.7% | 2.5% |
| 每股收益(稀释后) | $1.47 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
INCY
ROL
| Q1 26 | $1.3B | $906.4M | ||
| Q4 25 | $1.5B | $912.9M | ||
| Q3 25 | $1.4B | $1.0B | ||
| Q2 25 | $1.2B | $999.5M | ||
| Q1 25 | $1.1B | $822.5M | ||
| Q4 24 | $1.2B | $832.2M | ||
| Q3 24 | $1.1B | $916.3M | ||
| Q2 24 | $1.0B | $891.9M |
净利润
INCY
ROL
| Q1 26 | $303.3M | $107.8M | ||
| Q4 25 | $299.3M | $116.4M | ||
| Q3 25 | $424.2M | $163.5M | ||
| Q2 25 | $405.0M | $141.5M | ||
| Q1 25 | $158.2M | $105.2M | ||
| Q4 24 | $201.2M | $105.7M | ||
| Q3 24 | $106.5M | $136.9M | ||
| Q2 24 | $-444.6M | $129.4M |
毛利率
INCY
ROL
| Q1 26 | — | — | ||
| Q4 25 | 92.0% | — | ||
| Q3 25 | 92.8% | — | ||
| Q2 25 | 93.5% | — | ||
| Q1 25 | 93.0% | — | ||
| Q4 24 | 92.5% | — | ||
| Q3 24 | 92.4% | — | ||
| Q2 24 | 92.7% | — |
营业利润率
INCY
ROL
| Q1 26 | 23.7% | 16.1% | ||
| Q4 25 | 22.3% | 17.5% | ||
| Q3 25 | 32.5% | 21.9% | ||
| Q2 25 | 43.6% | 19.8% | ||
| Q1 25 | 19.5% | 17.3% | ||
| Q4 24 | 25.6% | 18.1% | ||
| Q3 24 | 12.8% | 20.9% | ||
| Q2 24 | -45.8% | 20.4% |
净利率
INCY
ROL
| Q1 26 | 23.8% | 11.9% | ||
| Q4 25 | 19.9% | 12.8% | ||
| Q3 25 | 31.1% | 15.9% | ||
| Q2 25 | 33.3% | 14.2% | ||
| Q1 25 | 15.0% | 12.8% | ||
| Q4 24 | 17.1% | 12.7% | ||
| Q3 24 | 9.4% | 14.9% | ||
| Q2 24 | -42.6% | 14.5% |
每股收益(稀释后)
INCY
ROL
| Q1 26 | $1.47 | $0.22 | ||
| Q4 25 | $1.46 | $0.24 | ||
| Q3 25 | $2.11 | $0.34 | ||
| Q2 25 | $2.04 | $0.29 | ||
| Q1 25 | $0.80 | $0.22 | ||
| Q4 24 | $0.90 | $0.22 | ||
| Q3 24 | $0.54 | $0.28 | ||
| Q2 24 | $-2.04 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $116.5M |
| 总债务越低越好 | — | $650.6M |
| 股东权益账面价值 | $5.6B | $1.4B |
| 总资产 | $7.3B | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.47× |
8季度趋势,按日历期对齐
现金及短期投资
INCY
ROL
| Q1 26 | — | $116.5M | ||
| Q4 25 | $3.1B | $100.0M | ||
| Q3 25 | $2.5B | $127.4M | ||
| Q2 25 | $2.0B | $123.0M | ||
| Q1 25 | $1.9B | $201.2M | ||
| Q4 24 | $1.7B | $89.6M | ||
| Q3 24 | $1.3B | $95.3M | ||
| Q2 24 | $987.3M | $106.7M |
总债务
INCY
ROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | — | $486.1M | ||
| Q3 25 | — | $485.7M | ||
| Q2 25 | — | $485.3M | ||
| Q1 25 | — | $485.5M | ||
| Q4 24 | — | $395.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益
INCY
ROL
| Q1 26 | $5.6B | $1.4B | ||
| Q4 25 | $5.2B | $1.4B | ||
| Q3 25 | $4.7B | $1.5B | ||
| Q2 25 | $4.2B | $1.4B | ||
| Q1 25 | $3.7B | $1.4B | ||
| Q4 24 | $3.4B | $1.3B | ||
| Q3 24 | $3.2B | $1.3B | ||
| Q2 24 | $3.0B | $1.2B |
总资产
INCY
ROL
| Q1 26 | $7.3B | $3.2B | ||
| Q4 25 | $7.0B | $3.1B | ||
| Q3 25 | $6.3B | $3.2B | ||
| Q2 25 | $5.8B | $3.2B | ||
| Q1 25 | $5.7B | $2.9B | ||
| Q4 24 | $5.4B | $2.8B | ||
| Q3 24 | $5.0B | $2.8B | ||
| Q2 24 | $4.7B | $2.8B |
负债/权益比
INCY
ROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.32× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.36× | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $118.4M |
| 自由现金流经营现金流 - 资本支出 | — | $111.2M |
| 自由现金流率自由现金流/营收 | — | 12.3% |
| 资本支出强度资本支出/营收 | — | 0.8% |
| 现金转化率经营现金流/净利润 | — | 1.10× |
| 过去12个月自由现金流最近4个季度 | — | $621.1M |
8季度趋势,按日历期对齐
经营现金流
INCY
ROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $543.3M | $164.7M | ||
| Q3 25 | $559.4M | $191.3M | ||
| Q2 25 | $44.7M | $175.1M | ||
| Q1 25 | $266.1M | $146.9M | ||
| Q4 24 | $381.2M | $188.2M | ||
| Q3 24 | $310.9M | $146.9M | ||
| Q2 24 | $-575.6M | $145.1M |
自由现金流
INCY
ROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | — | $159.0M | ||
| Q3 25 | — | $182.8M | ||
| Q2 25 | — | $168.0M | ||
| Q1 25 | — | $140.1M | ||
| Q4 24 | — | $184.0M | ||
| Q3 24 | — | $139.4M | ||
| Q2 24 | — | $136.4M |
自由现金流率
INCY
ROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | — | 17.4% | ||
| Q3 25 | — | 17.8% | ||
| Q2 25 | — | 16.8% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | — | 22.1% | ||
| Q3 24 | — | 15.2% | ||
| Q2 24 | — | 15.3% |
资本支出强度
INCY
ROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | — | 0.6% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.0% |
现金转化率
INCY
ROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | 1.82× | 1.41× | ||
| Q3 25 | 1.32× | 1.17× | ||
| Q2 25 | 0.11× | 1.24× | ||
| Q1 25 | 1.68× | 1.40× | ||
| Q4 24 | 1.89× | 1.78× | ||
| Q3 24 | 2.92× | 1.07× | ||
| Q2 24 | — | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图